San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story and see what’s trending.
News
News
News
Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market
BEIJING and SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ — Shenogen, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China … […]
News
Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market
BEIJING and SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ — Shenogen, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China … […]
News
2020 BIO International Convention Now Fully Digital
WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) announced today it will be moving the 2020 BIO International Convention scheduled for June 8-11 in San Diego to an online platform, in lieu of an in-person event for this year… […]
News
Halozyme Announces Change Of Location Of Annual Stockholders’ Meeting
SAN DIEGO, April 3, 2020 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that due to the emerging public health impact of the coronavirus outbreak (COVID-19), to support the health and well-being of our employees and stock… […]
News
SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGINS ENROLLING PATIENTS
SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced it has initiated the next phase of its collaboration with Celularity, Inc., a Warren, New Jersey, based clinical-stage cell therapeutics co… […]
News
Persephone Biosciences Announces AI-Driven Microbiome Therapeutic and Diagnostic Programs for COVID-19
Treatment approach goes beyond combating COVID-19 and may be effective against mutations, seasonal flu and future pandemics
SAN DIEGO, April 2, 2020 /PRNewswire/ — Persephone Biosciences Inc., a biotechnology company that designs microbiome therape… […]
News
ORIC Pharmaceuticals Appoints Christian V. Kuhlen, M.D., as General Counsel
SOUTH SAN FRANCISCO, Calif., April 2, 2020 /PRNewswire/ — ORIC Pharmaceuticals, Inc., a privately held, clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Christ… […]
News
Australia Patent Issued for Primer-Switch Mutation Detection and Amplification Platform
Expands Biocept’s intellectual property globally for methods of detecting rare mutations, including cancer biomarkers associated with circulating tumor DNA (ctDNA)
SAN DIEGO, April 2, 2020 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading comm… […]
News
Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment
Treatment with DAS181, a clinical-stage recombinant biologic, reduced or eliminated the need for supplemental oxygen, and improved key patient vital signs
SAN DIEGO, April 2, 2020 /PRNewswire/ — Ansun Biopharma, Inc., a clinical stage biopharmaceuti… […]
